X0708 D/A LIVE 0002087034 OrbiMed Asia Partners VI, L.P. 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY NEW YORK 10022 212-739-6400 CAYMAN ISLANDS None None Limited Partnership true 2025 N/A OrbiMed Asia GP VI, L.P. c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022 Executive Officer General Partner of the Issuer (the "GPLP") N/A OrbiMed Advisors VI Limited c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022 Executive Officer General Partner of the GPLP (the "GPLTD") Sven H. Borho c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022 Director Director of the GPLTD Carl L. Gordon c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022 Director Director of the GPLTD W. Carter Neild c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022 Director Director of the GPLTD Sunny Sharma Suite F 27, Grand Hyatt Plaza Santacruz (East) Mumbai K7 INDIA 400055 Director Director of the GPLTD David G. Wang Unit 2701, Jing An Kerry Centre Officer Tower 3, 1228 Yan'an Middle Road Shanghai F4 CHINA 200040 Director Director of the GPLTD Pooled Investment Fund Private Equity Fund false Not Applicable 06b 3C 3C.7 true 0002087034-25-000001 2025-09-30 false true false 0 UBS Switzerland AG None None None Bahnhofstrasse 45 Zurich V8 SWITZERLAND CH-8001 true MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED 7691 None None ONE BRYANT PARK NEW YORK NY NEW YORK 10036 All States false J.P. Morgan Securities LLC 79 None None 270 PARK AVENUE NEW YORK NY NEW YORK 10017 All States false 850000000 533984000 316016000 The total amount sold includes capital committed by the General Partner. false 45 0 true 0 true Paid based on a percentage of committed capital of investors introduced by selling agent. Management fees will be offset by any such amounts paid by the Issuer. Such amounts do not reduce the offering proceeds available for investment. 0 true An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the active investment period and a percentage tied to invested capital thereafter. false OrbiMed Asia Partners VI, L.P. /s/ W. Carter Neild W. Carter Neild Director of the GPLTD 2026-05-28